Victoza Sales Data

Rank 44 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Victoza U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 44 (5) 9.59% 3.73%
Q3 2013 49 (2) 4.95% -0.65%
Q2 2013 51 (9) 8.23% 2.14%
Q1 2013 60 (8) 6.43% 9.76%
Q4 2012 68 (6) 8.78% 7.17%
Q3 2012 74 (24) 27.22% 18.08%
Q2 2012 98 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
April 20, 2012Statement From Novo Nordisk Regarding the Petition to the FDA By Public Citizen
February 18, 2010FDA Approved Diabetes Drug Despite Hints at Cancer Risk
January 26, 2010Victoza Sanctioned for Type 2 Diabetes
Hide
(web2)